Cargando…
alpha-Sarcin catalytic activity is not required for cytotoxicity
BACKGROUND: α-Sarcin is a protein toxin produced by Aspergillus giganteus. It belongs to a family of cytotoxic ribonucleases that inactivate the ribosome and inhibit protein synthesis. α-Sarcin cleaves a single phosphodiester bond within the RNA backbone of the large ribosomal subunit, which makes t...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670844/ https://www.ncbi.nlm.nih.gov/pubmed/19344516 http://dx.doi.org/10.1186/1471-2091-10-9 |
_version_ | 1782166330461388800 |
---|---|
author | Alford, Spencer C Pearson, Joel D Carette, Amanda Ingham, Robert J Howard, Perry L |
author_facet | Alford, Spencer C Pearson, Joel D Carette, Amanda Ingham, Robert J Howard, Perry L |
author_sort | Alford, Spencer C |
collection | PubMed |
description | BACKGROUND: α-Sarcin is a protein toxin produced by Aspergillus giganteus. It belongs to a family of cytotoxic ribonucleases that inactivate the ribosome and inhibit protein synthesis. α-Sarcin cleaves a single phosphodiester bond within the RNA backbone of the large ribosomal subunit, which makes the ribosome unrecognizable to elongation factors and, in turn, blocks protein synthesis. Although it is widely held that the protein synthesis inhibition caused by the toxin leads to cell death, it has not been directly shown that catalytically inactive mutants of α-sarcin are non-toxic when expressed directly within the cytoplasm of cells. This is important since recent studies have cast doubt on whether protein synthesis inhibition is sufficient to initiate apoptosis. RESULTS: In this report, we assay α-sarcin cytotoxicity and ability to inhibit protein synthesis by direct cytoplasmic expression. We show that mutations in α-sarcin, which impair α-sarcin's ability to inhibit protein synthesis, do not affect its cytotoxicity. The mutants are unable to activate JNK, confirming that the sarcin-ricin loop remains intact and that the α-sarcin mutants are catalytically inactive. In addition, both mutant and wildtype variants of α-sarcin localize to the nucleus and cytoplasm, where they co-localize with ribosomal marker RPS6. CONCLUSION: We conclude that although protein synthesis inhibition likely contributes to cell death, it is not required. Thus, our results suggest that α-sarcin can promote cell death through a previously unappreciated mechanism that is independent of rRNA cleavage and JNK activation. |
format | Text |
id | pubmed-2670844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26708442009-04-21 alpha-Sarcin catalytic activity is not required for cytotoxicity Alford, Spencer C Pearson, Joel D Carette, Amanda Ingham, Robert J Howard, Perry L BMC Biochem Research Article BACKGROUND: α-Sarcin is a protein toxin produced by Aspergillus giganteus. It belongs to a family of cytotoxic ribonucleases that inactivate the ribosome and inhibit protein synthesis. α-Sarcin cleaves a single phosphodiester bond within the RNA backbone of the large ribosomal subunit, which makes the ribosome unrecognizable to elongation factors and, in turn, blocks protein synthesis. Although it is widely held that the protein synthesis inhibition caused by the toxin leads to cell death, it has not been directly shown that catalytically inactive mutants of α-sarcin are non-toxic when expressed directly within the cytoplasm of cells. This is important since recent studies have cast doubt on whether protein synthesis inhibition is sufficient to initiate apoptosis. RESULTS: In this report, we assay α-sarcin cytotoxicity and ability to inhibit protein synthesis by direct cytoplasmic expression. We show that mutations in α-sarcin, which impair α-sarcin's ability to inhibit protein synthesis, do not affect its cytotoxicity. The mutants are unable to activate JNK, confirming that the sarcin-ricin loop remains intact and that the α-sarcin mutants are catalytically inactive. In addition, both mutant and wildtype variants of α-sarcin localize to the nucleus and cytoplasm, where they co-localize with ribosomal marker RPS6. CONCLUSION: We conclude that although protein synthesis inhibition likely contributes to cell death, it is not required. Thus, our results suggest that α-sarcin can promote cell death through a previously unappreciated mechanism that is independent of rRNA cleavage and JNK activation. BioMed Central 2009-04-03 /pmc/articles/PMC2670844/ /pubmed/19344516 http://dx.doi.org/10.1186/1471-2091-10-9 Text en Copyright © 2009 Alford et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Alford, Spencer C Pearson, Joel D Carette, Amanda Ingham, Robert J Howard, Perry L alpha-Sarcin catalytic activity is not required for cytotoxicity |
title | alpha-Sarcin catalytic activity is not required for cytotoxicity |
title_full | alpha-Sarcin catalytic activity is not required for cytotoxicity |
title_fullStr | alpha-Sarcin catalytic activity is not required for cytotoxicity |
title_full_unstemmed | alpha-Sarcin catalytic activity is not required for cytotoxicity |
title_short | alpha-Sarcin catalytic activity is not required for cytotoxicity |
title_sort | alpha-sarcin catalytic activity is not required for cytotoxicity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670844/ https://www.ncbi.nlm.nih.gov/pubmed/19344516 http://dx.doi.org/10.1186/1471-2091-10-9 |
work_keys_str_mv | AT alfordspencerc alphasarcincatalyticactivityisnotrequiredforcytotoxicity AT pearsonjoeld alphasarcincatalyticactivityisnotrequiredforcytotoxicity AT caretteamanda alphasarcincatalyticactivityisnotrequiredforcytotoxicity AT inghamrobertj alphasarcincatalyticactivityisnotrequiredforcytotoxicity AT howardperryl alphasarcincatalyticactivityisnotrequiredforcytotoxicity |